RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences

Rhea-AI Summary

RAPT Therapeutics (Nasdaq: RAPT) said members of management will participate in three investor conferences in November 2025: Guggenheim's 2nd Annual Healthcare Innovation Conference, Stifel 2025 Healthcare Conference, and TD Cowen Virtual Immunology & Inflammation Summit.

Each participation is a fireside chat on consecutive days: Nov 11, 2025 at 3:30 p.m. ET, Nov 12, 2025 at 2:40 p.m. ET, and Nov 13, 2025 at 2:30 p.m. ET. Live webcasts and archived recordings will be available at https://investors.rapt.com/events-and-presentations.

News Market Reaction

-2.90%

3 alerts

-2.90% News Effect

-4.7% Trough Tracked

-$21M Valuation Impact

$709M Market Cap

0.5x Rel. Volume

On the day this news was published, RAPT declined 2.90%, reflecting a moderate negative market reaction. Argus tracked a trough of -4.7% from its starting point during tracking. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $21M from the company's valuation, bringing the market cap to $709M at that time.

Data tracked by StockTitan Argus on the day of publication.

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that members of the RAPT management team will participate in the following investor conferences in November:

• Guggenheim's 2nd Annual Healthcare Innovation Conference – Fireside chat on Tuesday, November 11, 2025 at 3:30 p.m. ET
  
  
• Stifel 2025 Healthcare Conference – Fireside chat on Wednesday, November 12, 2025 at 2:40 p.m. ET
  
  
• TD Cowen Virtual Immunology & Inflammation Summit – Fireside chat on Thursday, November 13, 2025 at 2:30 p.m. ET
  

To access the live webcasts or subsequent archived recordings of the fireside chats, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.

About RAPT Therapeutics, Inc.
RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases. Utilizing our deep and proprietary expertise in immunology, we develop novel therapies that are designed to modulate the critical immune responses underlying these diseases.

RAPT Investor Contact:
Sylvia Wheeler
swheeler@wheelhouselsa.com

RAPT Media Contact:
Aljanae Reynolds
areynolds@wheelhouselsa.com

FAQ

When will RAPT (NASDAQ: RAPT) present at Guggenheim's 2025 Healthcare Innovation Conference?

RAPT management will appear in a fireside chat on November 11, 2025 at 3:30 p.m. ET.

How can investors watch RAPT's Stifel 2025 Healthcare Conference fireside chat on November 12, 2025?

Watch the live webcast or archived recording via https://investors.rapt.com/events-and-presentations.

What time is RAPT's presentation at the TD Cowen Virtual Immunology & Inflammation Summit on November 13, 2025?

The fireside chat is scheduled for November 13, 2025 at 2:30 p.m. ET.

Are recordings of RAPT's November 2025 investor conference presentations available after the events?

Yes. Archived recordings will be accessible on the company's events and presentations page at https://investors.rapt.com/events-and-presentations.

Which RAPT executives will participate in the November 2025 fireside chats?

The announcement states that members of RAPT management will participate; specific names were not provided.